Massachusetts Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Weekly.

Press releases published on September 8, 2026

Sep. 8, 2026

Keros Therapeutics Announces $5 Million Share Repurchase Authorization

Indeterminate GlobeNewswire

Sep. 8, 2026

Celldex to Present at Upcoming Investor Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

Pyxis Oncology to Host Webcast to Present Updated Data from Phase 1 Monotherapy Study of Micvotabart Pelidotin (MICVO) in Second-Line and Beyond Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (2L+ R/M HNSCC)

Indeterminate GlobeNewswire

Sep. 8, 2026

LORii Expands Beyond Letters of Recommendation to Reinvent Modern Correspondence With AI

Indeterminate EIN Presswire

Sep. 8, 2026

The Jewelers Coin & Loan Co. Announces a Diamond Buying Event September 10 through September 30th

Indeterminate EIN Presswire

Sep. 8, 2026

Kadant Named to Newsweek's List of America's Greatest Companies 2026

Indeterminate GlobeNewswire

Sep. 8, 2026

IDC Appoints AI Marketing Veteran Avi Bhagtani as Chief Marketing Officer

Indeterminate GlobeNewswire

Sep. 8, 2026

Wyss Awarded ARPA-H Contract to End the Guesswork in Fetal Distress

Indeterminate GlobeNewswire

Sep. 8, 2026

Akari Therapeutics Selected to Showcase Novel PH1 ADC Payload Platform at Leading Global Oncology, ADC and Healthcare Forums

Indeterminate GlobeNewswire

Sep. 8, 2026

Payscale Launches Next-Generation Benchmarking with Ascent

Indeterminate GlobeNewswire

Sep. 8, 2026

Vericel to Present at the 24th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2026

Indeterminate GlobeNewswire

Sep. 8, 2026

Bone Biologics Expands Trial Sites

Indeterminate GlobeNewswire

Sep. 8, 2026

Lifeward Publishes Updated Investor Presentation Highlighting Commercial Growth Strategy

Indeterminate GlobeNewswire

Sep. 8, 2026

HYCU® Brings Enterprise-Class Data Protection to Azure DevOps with General Availability of HYCU R-Cloud™ for Azure DevOps

Indeterminate GlobeNewswire

Sep. 8, 2026

Liberty Defense Previews the HEXWAVE I-Configuration at GSX 2026 for Entrances That Cannot Give Up a Lane

Indeterminate GlobeNewswire

Sep. 8, 2026

Avalyn to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

Collegium to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 8, 2026

Flare Therapeutics Appoints Peter Lebowitz, MD, PhD, to Board of Directors and Brian DeSchuytner as Chief Financial Officer and Chief Business Officer

Indeterminate GlobeNewswire

Sep. 8, 2026

Intellia Therapeutics Announces FDA Acceptance of Biologics License Application with Priority Review for Lonvoguran Ziclumeran (Lonvo-z) for Hereditary Angioedema (HAE)

Indeterminate GlobeNewswire

Sep. 8, 2026

Avalyn Presents New Data at ERS Congress 2026 Supporting AP01 Lung Distribution and Patient-Centered Trial Design in Pulmonary Fibrosis

Indeterminate GlobeNewswire